City Therapeutics, Inc.
CTY- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0002143850
In the last 90 days, City Therapeutics, Inc. insiders filed 1 open-market purchase and 0 sales; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by City Therapeutics, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 1 filing
- 1 insider, $3.06M in total
- Open-market sells
- 0 filings
- Insiders trading
- 1
- Net value
- +$3.06M
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for City Therapeutics, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Crandell Keith | 10% Owner | 13,692,507Indirect | Oct 19, 2026 | 1 |
| Gillis Steven | 10% Owner | 13,692,507Indirect | Oct 19, 2026 | 1 |
| Burow Kristina | 10% Owner | 13,692,507Indirect | Oct 19, 2026 | 1 |
| ARCH Venture Fund XII, L.P. | 10% Owner | 13,692,507Indirect | Oct 19, 2026 | 1 |
| ARCH Venture Partners XII, LLC | 10% Owner | 13,692,507Indirect | Oct 19, 2026 | 1 |
| ARCH Venture Partners XII, L.P. | 10% Owner | 13,692,507Indirect | Oct 19, 2026 | 1 |
| Nelsen Robert | Director, 10% Owner | 13,692,507Indirect | Oct 19, 2026 | 1 |
| Maraganore John | Director | 1,470,692 | Oct 19, 2026 | 1 |
| Nochur Sara | Director | – | Oct 19, 2026 | 1 |
| Orth Andrew C. | President & CEO | – | Oct 19, 2026 | 1 |
| Philip Ron M | Director | – | Oct 19, 2026 | 1 |
| Greene Barry E | Director | – | Oct 19, 2026 | 1 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 19, 2026 (view filing)5:38 PM ET | Oct 19 | Same day | Crandell Keith and 5 others10% Owner | PPurchase | +170.0K | $18.00 | +$3.06M | +1.3%13.7M after | Duplicate filing |
| Oct 19, 2026 (view filing)5:37 PM ET | Oct 19 | Same day | Nelsen RobertDirector, 10% Owner | PPurchase | +170.0K | $18.00 | +$3.06M | +1.3%13.7M after |